Insider · CIK 0002017814
Jacob A. Waldrop
Files at SMTI (Sanara MedTech Inc.). First filing -, latest -.
In brief
Jacob A. Waldrop files SEC Form 4 as COO at SMTI (Sanara MedTech Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jacob A. Waldrop has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | SMTI Sanara MedTech Inc. | FTax withholding Common Stock | -378 | $20.01 | $7,564 | 24,377 | Apr 16, 2026 |
| Mar 22, 2026 | SMTI Sanara MedTech Inc. | AGrant or award Common Stock | -13,956 | $0.00 | $0 | 24,755 | Mar 23, 2026 |
| Feb 25, 2026 | SMTI Sanara MedTech Inc. | FTax withholding Common Stock | -714 | $19.90 | $14k | 10,799 | Feb 27, 2026 |
| Apr 15, 2025 | SMTI Sanara MedTech Inc. | FTax withholding Common Stock | -378 | $29.38 | $11k | 11,513 | Apr 17, 2025 |
| Apr 15, 2024 | SMTI Sanara MedTech Inc. | AGrant or award Common Stock | +3,101 | $0.00 | $0 | 3,101 | Apr 16, 2024 |
Questions about Jacob A. Waldrop
Answered from the filings on this page, as of the latest one.
Is Jacob A. Waldrop buying or selling?
Jacob A. Waldrop has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jacob A. Waldrop's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jacob A. Waldrop has 0.
Where does Jacob A. Waldrop file Form 4?
Jacob A. Waldrop has filed Form 4 at SMTI (Sanara MedTech Inc.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.